EOS Imaging recently announced the FDA has approved hipEOS, the company's new 3-D planning software for total hip arthroplasty procedures. Designed with the intent to improve preoperative planning, hipEOS allows surgeons to test everything from hip implant selection to positioning in functional, weight-bearing 3-D based on the anatomical data specific to each patient. These data stem from the company's stereo-radiographic 2-D/3-D imaging and represent the first instance of a software portfolio offered with the EOS imaging system, according to a company press release. This improvement in planning via hipEOS is believed to aid surgeons in the accuracy of the restoration they anticipate following THA.